PDA

View Full Version : Aromatase Inhibitor Benefit Continues After End of Treatment


tousled1
12-15-2007, 02:49 PM
Even after the end of treatment, anastrozole (Arimidex), an aromatase inhibitor, outperforms tamoxifen in women with hormone-receptor-positive early breast cancer, a researcher said here.<?XML:NAMESPACE PREFIX = O /><O:P></O:P>

<O:P></O:P>
<O:P>To read full article:</O:P>
<O:P>http://www.medpagetoday.com/MeetingCoverage/SABCSMeeting/tb/7707</O:P>